These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36212408)

  • 1. LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT.
    Khan MI; Ahmad A
    Front Oncol; 2022; 12():1015428. PubMed ID: 36212408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.
    Ahmad A; Ginnebaugh KR; Yin S; Bollig-Fischer A; Reddy KB; Sarkar FH
    BMC Cancer; 2015 Jul; 15():540. PubMed ID: 26206152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.
    Gao Y; Zhang W; Liu C; Li G
    Sci Rep; 2019 Dec; 9(1):18844. PubMed ID: 31827114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis.
    Zhang M; Duan W; Sun W
    Onco Targets Ther; 2019; 12():3349-3360. PubMed ID: 31118686
    [No Abstract]   [Full Text] [Related]  

  • 5. LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944.
    Mao D; Jie Y; Lv Y
    Cancer Biother Radiopharm; 2022 May; 37(4):246-255. PubMed ID: 32935999
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
    Wang YQ; Huang G; Chen J; Cao H; Xu WT
    Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.
    Meng Q; Yang BY; Liu B; Yang JX; Sun Y
    Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
    Liu XF; Wang K; Du HC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA SNHG6 regulates the sensitivity of prostate cancer cells to paclitaxel by sponging miR-186.
    Cao C; Sun G; Liu C
    Cancer Cell Int; 2020; 20():381. PubMed ID: 32782439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
    Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y
    Front Oncol; 2021; 11():678474. PubMed ID: 34026654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944.
    Gao G; Li X; Wu H; Huang LL; Lin YX; Huo Z; Xiang ZY; Zhou X
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing lncRNA SNHG6 suppresses proliferation and invasion of breast cancer cells through miR-26a/VASP axis.
    Li K; Ma YB; Tian YH; Xu XL; Gao Y; He YQ; Pan WT; Zhang JW; He CJ; Wei L
    Pathol Res Pract; 2019 Oct; 215(10):152575. PubMed ID: 31387807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 16. LncRNA SNHG6 Inhibits Apoptosis by Regulating EZH2 Expression via the Sponging of MiR-101-3p in Esophageal Squamous-Cell Carcinoma.
    Wang J; Yang X; Li R; Zhang R; Hu D; Zhang Y; Gao L
    Onco Targets Ther; 2020; 13():11411-11420. PubMed ID: 33192074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA SNHG6 Supports Glioma Progression Through Upregulation of Notch1, Sox2, and EMT.
    Nie J; Feng Y; Wang H; Lian XY; Li YF
    Front Cell Dev Biol; 2021; 9():707906. PubMed ID: 34485294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
    Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W; Zhang Y; Fang P; Shi H; Yang S
    Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.